Novel biomarkers of the metabolism of caffeic acid derivatives in vivo

被引:224
作者
Rechner, AR
Spencer, JPE
Kuhnle, G
Hahn, U
Rice-Evans, CA
机构
[1] Kings Coll London, Antioxidant Res Ctr, Wolfson Ctr Age Related Dis, Guys Kings & St Thomas Sch Biomed Sci, London SE1 9RT, England
[2] Univ Leipzig, Inst Biochem, Fac Life Sci Pharm & Psychol, D-7010 Leipzig, Germany
关键词
bioavailability; hydroxycinnamate metabolism; chlorogenic acid; isoferulic acid; dihydroferulic acid; ferulic acid; caffeic acid; free radicals;
D O I
10.1016/S0891-5849(01)00506-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
The purpose of this study was to investigate biomarkers of the bioavailability and metabolism of hydroxy cinnamate derivatives through the determination of the pharmacokinetics of their urinary elimination and identification of the metabolites excreted. Coffee was used as a rich source of caffeic acid derivatives and human supplementation was undertaken. The results show a highly significant increase in the excretion of ferulic, isoferulic, dihydroferulic acid (3-(4-hydroxy-3-methoxyphenyl)-propionic acid), and vanillic acid postsupplementation relative to the levels presupplementation. Thus, ferulic, isoferulic, and dihydroferulic acids are specific biomarkers for the bioavailability and metabolism of dietary caffeic acid esters. Isoferulic acid is a unique biomarker as it is not a dietary component, however, dihydroferulic acid may well derive from other flavonoids with a structurally related B-ring. 3-Hydroxyhippuric acid has also been identified as an indicator for bioavailability and metabolism of phenolic compounds, and shows a highly significant excretion increase postsupplementation. The results reveal isoferulic acid (and possibly dihydroferulic acid) as novel markers of caffeoyl quinic acid metabolism. (C) 2001 Elsevier Science Inc.
引用
收藏
页码:1213 / 1222
页数:10
相关论文
共 28 条
[1]
ANDREONI V, 1995, APPL MICROBIOL BIOT, V42, P830, DOI 10.1007/BF00191177
[2]
[Anonymous], 1976, Biochem J, V153, P23
[3]
BOOTH AN, 1957, J BIOL CHEM, V229, P51
[4]
Cheng ZQ, 1999, DRUG METAB DISPOS, V27, P1165
[5]
Chesson A, 1999, J SCI FOOD AGR, V79, P373, DOI 10.1002/(SICI)1097-0010(19990301)79:3&lt
[6]
373::AID-JSFA257&gt
[7]
3.0.CO
[8]
2-6
[9]
Clifford MN, 1999, J SCI FOOD AGR, V79, P362, DOI [10.1002/(SICI)1097-0010(19990301)79:3&lt
[10]
362::AID-JSFA256&gt